![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Cll Pharma Nice Cedex 3 Fr, based in France, is a pharmaceutical company.
One of their significant offerings is Spiramycin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1998-063 - Rev 01
This Chemical Type CEP, issued on July 30, 2009, remains in force until June 08, 2022, ensuring its reliability within the pharmaceutical industry.
Substance Number 293 associated with this CEP further emphasizes